Top Banner
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Antibiotics Chapter 09
61

Ppt chapter 09

Jan 19, 2015

Download

Documents

stanbridge

 
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AntibioticsAntibiotics

Chapter 09

Page 2: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AntibioticsAntibiotics

• Antibiotics are defined as:

– Chemicals that inhibit specific bacteria

– Made in three ways

• By living microorganisms

• By synthetic manufacture

• Through genetic engineering

Page 3: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Types of AntibioticsTypes of Antibiotics

• Bacteriostatic

– Those substances that prevent the growth of bacteria

• Bactericidal

– Those that kill bacteria directly

Page 4: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Signs of InfectionSigns of Infection

• Fever

• Lethargy

• Slow-wave sleep induction

• Classic signs of inflammation (redness, swelling, heat, and pain)

Page 5: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Goal of Antibiotic TherapyGoal of Antibiotic Therapy

• Decrease the population of the invading bacteria to a point where the human immune system can effectively deal with the invader

Page 6: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Selecting TreatmentSelecting Treatment

• Identification of the causative organism

• Based on the culture report, an antibiotic is chosen that has been known to be effective at treating the invading organism

Page 7: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Bacteria ClassificationBacteria Classification

• Gram-positive

– The cell wall retains a stain or resists decolorization with alcohol

• Gram-negative

– The cell wall loses a stain or is decolorized by alcohol

• Aerobic

– Depend on oxygen for survival

• Anaerobic

– Do not use oxygen

Page 8: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Bacteria and Resistance to AntibioticsBacteria and Resistance to Antibiotics

• Adapt to their environment

• The longer an antibiotic has been in use, the greater the chance that the bacteria will develop into a resistant strain

Page 9: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AminoglycosidesAminoglycosides

• A group of powerful antibiotics used to treat serious infections caused by gram-negative aerobic bacilli

• Common medications:

– Amikacin (Amikin)

– Gentamicin (Garamycin)

– Kanamycin (Kantrex)

– Neomycin (Mycifradin)

– Streptomycin

– Tobramycin (Nebcin, Tobrex)

Page 10: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Aminoglycosides (cont.)Aminoglycosides (cont.)

• Bactericidal

• Indications: Treatment of serious infections caused by susceptible bacteria

• Actions: Inhibits protein synthesis in susceptible strains of gram-negative bacteria causing cell death

Page 11: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Aminoglycosides (cont.)Aminoglycosides (cont.)

• Pharmacokinetics

– Poorly absorbed from the GI tract, but rapidly absorbed after IM injection, reaching peak levels within 1 hour

– Widely distributed throughout the body, crossing the placenta and entering breast milk

– Excreted unchanged in the urine and have an average half-life of 2 to 3 hours

– Depend on the kidney for excretion and are toxic to the kidney

Page 12: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Aminoglycosides (cont.)Aminoglycosides (cont.)

• Contraindications

– Known allergies, renal or hepatic disease, hearing loss

• Adverse Effects

– Ototoxicity and nephrotoxicity are the most significant

• Drug-to-Drug Interactions

– Diuretics, neuromuscular blockers

Page 13: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

Tell whether the following statement is true or false.

Because of the adverse effects of the aminoclycosides, it is important to teach the patient to restrict fluids and eat 6

small meals daily.

Page 14: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

False

Rationale: Provide the following patient teaching: Try to drink a lot of fluids and to maintain nutrition (very

important) even though nausea, vomiting, and diarrhea may occur.

Page 15: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Patients Receiving Aminoglycosides

Nursing Considerations for Patients Receiving Aminoglycosides

• Assessment: History and Examination

• Nursing Diagnoses

• Implementation With Rationale

• Evaluation

Page 16: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: GentamicinPrototype Summary: Gentamicin

Page 17: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

CarbapenemsCarbapenems

• Therapeutic Actions and Indications

• Pharmacokinetics

• Contraindications and Cautions

• Adverse Effects

• Clinically Important Drug–Drug Interactions

Page 18: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Patients Receiving Carbapenems

Nursing Considerations for Patients Receiving Carbapenems

• Assessment: History and Examination

• Nursing Diagnoses

• Implementation With Rationale

• Evaluation

Page 19: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: ErtapenemPrototype Summary: Ertapenem

Page 20: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

CephalosporinsCephalosporins

• Similar to penicillin in structure and activity

• Action

– Interfere with the cell wall–building ability of bacteria when they divide

• Indications

– Treatment of infections caused by susceptible bacteria

• Pharmacokinetics

– Well absorbed from the GI tract

– Metabolized in the liver, excreted in the urine

Page 21: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Cephalosporins (cont.)Cephalosporins (cont.)

• Contraindications

– Allergies to cephalosporins or penicillin

• Adverse Effects

– GI track

• Drug-to-Drug Interactions

– Aminoglycosides, oral anticoagulants, ETOH

Page 22: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Patients Receiving Cephalosporins

Nursing Considerations for Patients Receiving Cephalosporins

• Assessment: History and Examination

• Nursing Diagnoses

• Implementation With Rationale

• Evaluation

Page 23: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: CefaclorPrototype Summary: Cefaclor

Page 24: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

You are writing a plan of care for a patient receiving Cefaclor. What would be an appropriate nursing diagnosis for this patient?

A. Deficient fluid volume and imbalanced nutrition: Less than body requirements, related to diarrhea

B. Chronic pain related to GI, CNS effects of drug

C. Monitor renal function test values

D. Perform culture and sensitivity tests at the site of infection

Page 25: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

a. Deficient fluid volume and imbalanced nutrition: Less than body requirements, related to diarrhea

Rationale: Nursing diagnoses related to drug therapy might include: Acute Pain related to GI, CNS effects of drug; Risk for infection related to repeated injections; Deficient fluid volume and imbalanced nutrition: Less than body requirements, related to diarrhea; Deficient knowledge regarding drug therapy

Page 26: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

FluoroquinolonesFluoroquinolones• Relatively new class of antibiotics with a broad spectrum of activity

• Indications: Treating infections caused by susceptible strains of gram-negative bacteria. Includes: urinary track, respiratory track, and skin infections

• Actions: Interferes with DNA replication in susceptible gram-negative bacteria, preventing cell reproduction

• Pharmacokinetics:

– Absorbed in GI tract

– Metabolized in the liver

– Excreted in urine and feces

Page 27: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Fluoroquinolones (cont.)Fluoroquinolones (cont.)

• Contraindications

– Known allergy, pregnancy, or lactating women

• Adverse Effects

– Headache, dizziness, GI upset

• Drug-to-Drug Interactions

– Antacids, quinidine, theophylline

Page 28: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Patients Receiving Fluoroquinolones

Nursing Considerations for Patients Receiving Fluoroquinolones

• Assessment: History and Examination

• Nursing Diagnoses

• Implementation With Rationale

• Evaluation

Page 29: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: CiprofloxacinPrototype Summary: Ciprofloxacin

Page 30: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

What is a contraindication to receiving a fluoroquinolones?

A. Over 65 years

B. Weight under 100 pounds

C. Fluoroquinolones are contraindicated in patients with known allergy to any fluoroquinolone.

D. History of cancer

Page 31: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

c. Fluoroquinolones are contraindicated in patients with known allergy to any fluoroquinolone.

Rationale: Fluoroquinolones are contraindicated in patients with known allergy to any fluoroquinolone and in pregnant or lactating patients because potential effects on the fetus and infant are not known.

Page 32: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Penicillins and Penicillinase - Resistant Antibiotics

Penicillins and Penicillinase - Resistant Antibiotics

• Therapeutic Actions and Indications

• Pharmacokinetics

• Contraindications and Cautions

• Adverse Effects

• Clinically Important Drug–Drug Interactions

Page 33: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Patients Receiving Penicillins and Penicillinase-

Resistant Antibiotics

Nursing Considerations for Patients Receiving Penicillins and Penicillinase-

Resistant Antibiotics

• Assessment: History and Examination

• Nursing Diagnoses

• Implementation With Rationale

• Evaluation

Page 34: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: AmoxicillinPrototype Summary: Amoxicillin

Page 35: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

SulfonamidesSulfonamides• Drugs that inhibit folic acid synthesis

• Action

– Interfere with the cell wall–building ability of bacteria when they divide

• Indications

– Treatment of infections caused by gram-negative and gram-positive bacteria

• Pharmacokinetics

– Well absorbed from the GI tract

– Metabolized in the liver, excreted in the urine

Page 36: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Sulfonamides (cont.)Sulfonamides (cont.)

• Contraindications

– Allergy, pregnancy

• Adverse Effects

– GI symptoms; Renal effects related to the filtration of the drug

• Drug-to-Drug Interactions

– Cross sensitivity with thiazide diuretics

– Sulfonylureas

Page 37: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Patients Receiving Sulfonamides

Nursing Considerations for Patients Receiving Sulfonamides

• Assessment: History and Examination

• Nursing Diagnoses

• Implementation With Rationale

• Evaluation

Page 38: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: CotrimoxazolePrototype Summary: Cotrimoxazole

Page 39: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

TetracyclinesTetracyclines

• Developed as semisynthetic antibiotics based on the structure of a common soil mold

• Action

– Inhibits protein synthesis in susceptible bacteria, preventing cell replication

• Indications

– Treatment of various infections caused by susceptible strains of bacteria; acne when penicillin is contraindicated for eradication of susceptible organisms

• Pharmacokinetics

– Adequately absorbed from the GI tract

– Concentrated in the liver, excreted unchanged in the urine

Page 40: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Tetracyclines (cont.)Tetracyclines (cont.)

• Contraindications

– Allergy, pregnancy, and lactation

• Adverse Effects

– GI, Skeletal – damage to bones and teeth

• Drug-to-Drug Interactions

– Penicillin G, oral contraceptive therapy, methoxyflurane, digoxin

Page 41: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Patients Receiving Tetracyclines

Nursing Considerations for Patients Receiving Tetracyclines

• Assessment: History and Examination

• Nursing Diagnoses

• Implementation With Rationale

• Evaluation

Page 42: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: TetracyclinePrototype Summary: Tetracycline

Page 43: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

Tell whether the following statement is true or false.

Sulfonamides should not be given with thiazide diuretics because of a cross sensitivity of the drugs.

Page 44: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

True

Rationale: Drug-to-Drug Interactions: Cross sensitivity with thiazide diuretics; Sulfonareas

Page 45: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AntimycobacterialAntimycobacterial

• Contain pathogens causing TB and leprosy

• Action

– Act on the DNA of the bacteria leading to lack of growth and eventual bacterial death

• Indications

– Treatment of acid fast bacteria

• Pharmacokinetics

– Well absorbed from the GI tract

– Metabolized in the liver, excreted in the urine

Page 46: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AntimycobacterialAntimycobacterial

• Contraindications

– Allergy, renal or hepatic failure

• Adverse Effects

– CNS effects and GI irritation

• Drug-to-Drug Interactions

– Rifampin and INH can cause liver toxicity

Page 47: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Patients Receiving Antimycobacterials

Nursing Considerations for Patients Receiving Antimycobacterials

• Assessment: History and Examination

• Nursing Diagnoses

• Implementation With Rationale

• Evaluation

Page 48: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: IsoniazidPrototype Summary: Isoniazid

Page 49: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Other AntibioticsOther Antibiotics

• Ketolides

– Therapeutic Actions and Indications

– Pharmacokinetics

– Contraindications and Cautions

– Adverse Effects

– Clinically Important Drug-Drug Interactions

Page 50: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: TelithromycinPrototype Summary: Telithromycin

Page 51: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Other Antibiotics (cont.)Other Antibiotics (cont.)

• Lincosamides

– Therapeutic Actions and Indications

– Pharmacokinetics

– Contraindications and Cautions

– Adverse Effects

Page 52: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: ClindamycinPrototype Summary: Clindamycin

Page 53: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Other Antibiotics (cont.)Other Antibiotics (cont.)

• Macrolides

– Therapeutic Actions and Indications

– Pharmacokinetics

– Contraindications and Cautions

– Adverse Effects

– Clinically Important Drug–Drug Interactions

– Clinically Important Drug–Food Interactions

Page 54: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: ErythromycinPrototype Summary: Erythromycin

Page 55: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Other Antibiotics (cont.)Other Antibiotics (cont.)

• Monobactam Antibiotic

– Therapeutic Actions and Indications

– Pharmacokinetics

– Contraindications and Cautions

– Adverse Effects

Page 56: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Prototype Summary: AztreonamPrototype Summary: Aztreonam

Page 57: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Considerations for Patients Receiving Other Antibiotics

Nursing Considerations for Patients Receiving Other Antibiotics

• Assessment: History and Examination

• Nursing Diagnoses

• Implementation With Rationale

• Evaluation

Page 58: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

The macrolide antibiotics have known food-drug interactions. What would you teach your patient taking a macrolide antibiotic?

A. Take with meals

B. Take daily just before going to bed

C. Take daily upon arising in the morning

D. Take 1 hour before or at least 2 to 3 hours after meals

Page 59: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

D. Take 1 hour before or at least 2 to 3 hours after meals

Rationale: Food in the stomach decreases absorption of oral macrolides. Therefore, administer the antibiotic on an empty stomach with a full, 8-oz glass of water, 1 hour before or at least 2 to 3 hours after meals.

Page 60: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

New Classes of Antibiotics and Adjuncts New Classes of Antibiotics and Adjuncts

• Daptomycin

• Linezolid (Zyvox)

• Tigecycline

• Streptogramins

Page 61: Ppt chapter 09

Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Antibiotic Use Across the Life SpanAntibiotic Use Across the Life Span

• Pediatric Population

• Adult Population

• Geriatric Population